Julia C. Gage (United States of America)
National Cancer Institute Division of Cancer Epidemiology and Genetics
Presenter of 1 Presentation
AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENTE NORTHERN CALIFORNIA (ID 1342)
Session Time
12:20 - 14:20
Session Type
Public Health Oral Session
Lecture Time
12:56 - 13:08
[{"name":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENTE NORTHERN CALIFORNIA \u003Csmall\u003E(ID 1342)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1342,"presentation":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENTE NORTHERN CALIFORNIA \u003Csmall\u003E(ID 1342)\u003C\/small\u003E","session":"Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Julia C. Gage (United States of America)","photo":""},"playlist":[{"name":"AN INITIAL DESCRIPTION OF THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY AT KAISER PERMANENT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/45A7A552.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/44\/GMT20200630-161215_Julia-Gage_1686x768-0.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22UU0p9"}
[session]
[presentation]
[presenter]
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
12:35 - 13:50
[{"name":"DETECTION OF SOMATIC HOTSPOT MUTATIONS IN CERVICAL PRECANCEROUS LESIONS USING CERVICAL CELLS. \u003Csmall\u003E(ID 1046)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1046,"presentation":"DETECTION OF SOMATIC HOTSPOT MUTATIONS IN CERVICAL PRECANCEROUS LESIONS USING CERVICAL CELLS. \u003Csmall\u003E(ID 1046)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Maisa Pinheiro (United States of America)","photo":""},"playlist":[{"name":"9c770ce5c4dd9cb4dee0497d8a37a98a","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/BCFC07F6.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/9c770ce5c4dd9cb4dee0497d8a37a98a.vtt"}]},{"name":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, HPV33, HPV45, HPV52 & HPV58 \u003Csmall\u003E(ID 553)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":553,"presentation":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, HPV33, HPV45, HPV52 & HPV58 \u003Csmall\u003E(ID 553)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Dianna E. Wilkinson (United Kingdom)","photo":""},"playlist":[{"name":"WHO INTERNATIONAL STANDARDS FOR HPV DNA FOR LOW-RISK TYPES HPV6 & HPV11 AND HIGH-RISK TYPES HPV31, H","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/52D80A43.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/GMT20200611-124951_Dianna-Wil_1920x1080.vtt"}]},{"name":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER \u003Csmall\u003E(ID 162)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":162,"presentation":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER \u003Csmall\u003E(ID 162)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Jiangrong Wang (Sweden)","photo":""},"playlist":[{"name":"FOLLOW-UP OF ATYPIAL GLANDULAR CELLS: RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVIC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/1BCEBB2A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Jiangrong Wang - IPVC20 - 162 - FOLLOW-UP OF ATYPIAL GLANDULAR CELLS RAPID HISTOPATHOLOGY ASSOCIATED WITH LOWER INCIDENCE OF CERVICAL CANCER.vtt"}]},{"name":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN \u003Csmall\u003E(ID 901)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":901,"presentation":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN \u003Csmall\u003E(ID 901)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Bengt Andrae (Sweden)","photo":""},"playlist":[{"name":"ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/B0AC2C2B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Bengt Andrae -IPVC20 - 901 -ANALYSIS OF THE RECENT INCREASE IN CERVICAL CANCER INCIDENCE IN SWEDEN.vtt"}]},{"name":"CERVICAL PRECANCER (CIN2\/3\/AIS) LATER DIAGNOSED WITH CERVICAL CANCER BY SOCIODEMOGRAPHIC FACTORS, SEVERITY OF DIAGNOSIS, AND HPV-TYPE, ALAMEDA COUNTY, CALIFORNIA, UNITED STATES (U.S.), 2008-2018 \u003Csmall\u003E(ID 1055)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1055,"presentation":"CERVICAL PRECANCER (CIN2\/3\/AIS) LATER DIAGNOSED WITH CERVICAL CANCER BY SOCIODEMOGRAPHIC FACTORS, SEVERITY OF DIAGNOSIS, AND HPV-TYPE, ALAMEDA COUNTY, CALIFORNIA, UNITED STATES (U.S.), 2008-2018 \u003Csmall\u003E(ID 1055)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Erin Whitney (United States of America)","photo":""},"playlist":[{"name":"Martina Rojnic Kuzman - EPA2020 - 4,963 - Can Psychosocial Treatment Reduce Antipsychotic-Induced Me","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/7AA7C450.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Erin Whitney - Record your lecture - IPVC20.vtt"}]},{"name":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A WORLDWIDE STUDY \u003Csmall\u003E(ID 531)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":531,"presentation":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A WORLDWIDE STUDY \u003Csmall\u003E(ID 531)\u003C\/small\u003E","session":"Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors\u00a0","presenter":"Iacopo Baussano (France)","photo":""},"playlist":[{"name":"PREDICTING COHORT-SPECIFIC CERVICAL CANCER INCIDENCE FROM POPULATION-BASED HPV PREVALENCE SURVEYS: A","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/7BA30EE1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/59\/Iacopo Baussano - IPVC20 - PRESENTATION 531.vtt"}]}]
{"type":2,"code":"7E32UU022"}
[session]
[presentation]
[presenter]
